Location:
Chengdu, China (Relocation Supported), the first year of employment can be remote. BioTalent is conducting a search for a senior biologics R&D executive to lead a large-scale innovation organization focused on next-generation immunology and oncology drug development. We are looking for a leader currently based in North America who is interested in relocating to China to lead a major biologics R&D organization. This is a rare opportunity to take ownership of a biologics portfolio spanning tumor immunology, T-cell engagers (TCEs), ADCs, and next-generation immunotherapies. Reporting directly to the Chairman and President, this leader will shape R&D strategy, drive scientific innovation, and build a globally competitive pipeline with strong partnering and out-licensing potential.
Key Responsibilities:
Define and execute biologics portfolio strategy aligned with unmet clinical needs.
Lead scientific direction across tumor immunology, PD-1 based therapies, TCEs, multispecific antibodies, and ADC programs.
Drive innovation through assessment and implementation of novel platform technologies.
Guide programs from discovery through IND-enabling studies and clinical translation.
Partner with clinical development teams on early-stage clinical strategy and protocol design.
Lead, develop, and scale multidisciplinary R&D teams across discovery, preclinical, and process development.
Support business development activities through scientific due diligence and asset evaluation.
Bilingual in English and Mandarin
Ideal Background:
PhD in Immunology, Tumor Biology, or a related life sciences discipline.10+ years of biologics drug discovery and development experience within biotech or large pharmaceutical environments.5+ years of leadership experience at Director level or above.
Demonstrated success advancing biologics programs from target discovery through IND.Deep expertise in tumor immunology, PD-1 mechanisms, T-cell engagers, bispecific antibodies, or ADCs.
Experience supporting successful licensing transactions or advancing assets into clinical development strongly preferred.
Strong strategic leadership capabilities combined with scientific excellence.
Relocation Package:
Family accommodation provided.
Company vehicle provided.
Flexible remote working arrangements.
Significant opportunity to influence global biologics innovation strategy.Greg.Hammond@biotalent.com
